Kannt et al. [218] reported that the treatment of mice with a nicotinamide analogue inhibitor of NNMT (JBSNF-00008) reduced the body weight, improved the insulin sensitivity, and normalized the glucose tolerance in mice with high-fat-diet-induced obesity. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.